1. Home
  2. HALO vs LAD Comparison

HALO vs LAD Comparison

Compare HALO & LAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • LAD
  • Stock Information
  • Founded
  • HALO 1998
  • LAD 1946
  • Country
  • HALO United States
  • LAD United States
  • Employees
  • HALO N/A
  • LAD N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • LAD Retail-Auto Dealers and Gas Stations
  • Sector
  • HALO Health Care
  • LAD Consumer Discretionary
  • Exchange
  • HALO Nasdaq
  • LAD Nasdaq
  • Market Cap
  • HALO 7.4B
  • LAD 7.6B
  • IPO Year
  • HALO N/A
  • LAD 1996
  • Fundamental
  • Price
  • HALO $50.23
  • LAD $326.23
  • Analyst Decision
  • HALO Buy
  • LAD Strong Buy
  • Analyst Count
  • HALO 9
  • LAD 13
  • Target Price
  • HALO $63.78
  • LAD $375.15
  • AVG Volume (30 Days)
  • HALO 2.6M
  • LAD 336.6K
  • Earning Date
  • HALO 05-06-2025
  • LAD 04-23-2025
  • Dividend Yield
  • HALO N/A
  • LAD 0.67%
  • EPS Growth
  • HALO 55.40
  • LAD N/A
  • EPS
  • HALO 3.76
  • LAD 31.74
  • Revenue
  • HALO $1,084,306,000.00
  • LAD $36,804,700,000.00
  • Revenue This Year
  • HALO $24.79
  • LAD $8.04
  • Revenue Next Year
  • HALO $22.65
  • LAD $7.36
  • P/E Ratio
  • HALO $13.36
  • LAD $10.27
  • Revenue Growth
  • HALO 25.64
  • LAD 12.81
  • 52 Week Low
  • HALO $41.28
  • LAD $243.04
  • 52 Week High
  • HALO $70.51
  • LAD $405.68
  • Technical
  • Relative Strength Index (RSI)
  • HALO 34.42
  • LAD 65.70
  • Support Level
  • HALO $58.38
  • LAD $292.97
  • Resistance Level
  • HALO $69.94
  • LAD $329.26
  • Average True Range (ATR)
  • HALO 3.30
  • LAD 8.35
  • MACD
  • HALO -0.27
  • LAD 4.09
  • Stochastic Oscillator
  • HALO 9.30
  • LAD 86.22

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About LAD Lithia Motors Inc.

Lithia Motors is a retailer of new and used vehicles and related services. The company offers over 50 brands of vehicles at nearly 500 stores globally across the US, Canada, and UK. The company has expanded largely through the acquisition of dealerships in smaller regional markets but now seeks to grow in any part of the US and we expect more deals over time in the US and, at times, abroad. Annual revenue in 2024 was $36.2 billion and we see over $50 billion possible in a few years. The US was 78% of 2024 revenue and the UK second at 19%, due to the 2024 Pendragon acquisition. In 2024, new vehicle sales were about 49% of total revenue. Lithia was founded in 1946, went public in 1996, and is the largest US auto dealer. It is based in Medford, Oregon.

Share on Social Networks: